Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial
Open Access
- 15 January 2008
- journal article
- clinical trial
- Published by Springer Nature in Critical Care
- Vol. 12 (1) , R4
Abstract
Introduction: Circulatory dysfunction in cirrhotic patients may cause a specific kind of functional renal failure termed hepato-renal syndrome (HRS). It contributes to the high incidence of renal failure in cirrhotic intensive care unit (ICU) patients. Fluid therapy may aggravate renal failure by increasing ascites and intra-abdominal pressure (IAP). This study investigates the short-term effects of paracentesis on haemodynamics and kidney function in volume resuscitated patients with HRS. Methods: Nineteen consecutive cirrhotic patients with HRS were studied. Circulatory parameters and renal function were analysed before and after plasma expansion and paracentesis. Haemodynamic monitoring was performed by transpulmonary thermodilution. Results: After infusion of 200 ml of 20% human albumin solution, mean arterial pressure (MAP) and central venous pressure remained unchanged. Global end-diastolic volume index (GEDVI) increased from 791 ml m-2 (693 to 862) (median and 25th to 75th percentile) to 844 ml m-2 (751 to 933). Cardiac index (CI) increased from 4.1 l min-1 m-2 (3.6 to 5.0) to 4.7 l min-1 m-2 (4.0 to 5.8), whereas systemic vascular resistance index (SVRI) decreased from 1,422 dyn s cm-5 m-2 (1,081 to 1,772) to 1,171 dyn s cm-5 m-2 (893 to 1,705). Creatinine clearance (CC) and fractional excretion of sodium (FeNa) were not affected. During paracentesis, IAP decreased from 22 mmHg (18 to 24) to 9 mmHg (8 to 12). MAP decreased from 81 mmHg (74 to 100) to 80 mmHg (71 to 89), and CI increased from 4.1 l min-1 m-2 (3.2 to 4.3) to 4.2 l min-1 m-2 (3.6 to 4.7), whereas SVRI decreased from 1,639 dyn s cm-5 m-2 (1,168 to 2,037) to 1,301 dyn s cm-5 m-2 (1,124 to 1,751). CC during the 12-hour interval after paracentesis was significantly higher than during the 12 hours before (33 ml min-1 (16 to 50) compared with 23 ml min-1 (12 to 49)). CC remained elevated for the rest of the observation period. FeNa increased after paracentesis but returned to baseline levels after 24 hours. Conclusion: Paracentesis with parameter-guided fluid substitution and maintenance of central blood volume may improve renal function and is safe in the treatment of ICU patients with hepato-renal failure.Keywords
This publication has 28 references indexed in Scilit:
- Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitisJournal of Hepatology, 2004
- Acute renal failure in patients with cirrhosis: Perspectives in the age of MELDHepatology, 2003
- Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized studyHepatology, 2002
- Abdominal decompression plays a major role in early postparacentesis haemodynamic changes in cirrhotic patients with tense ascitesGut, 2001
- Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial PeritonitisNew England Journal of Medicine, 1999
- Haemodynamic effects of pneumoperitoneum in elderly patients with an increased cardiac riskEuropean Journal of Anaesthesiology, 1997
- Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†Hepatology, 1996
- Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trialLiver International, 1993
- Pressure dependent modulation of renin release in isolated perfused glomeruliKidney International, 1992
- Analysis of HLA class II genes in Japanese patients with idiopathic membranous glomerulonephritisKidney International, 1992